Mosaic ImmunoEngineering Inc

OTC: CPMV    
Share price (3/26/24): $0.35    
Market cap (3/26/24): $2.524 million

Material Contracts Filter

EX-10.1
from 8-K 2 pages Amendment No. 1 to Series a Preferred Stock Redemption Agreement
12/34/56
EX-10.1
from 10-Q 26 pages Certain Information in This Document, Marked by [**], Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10)(iv). Such Excluded Information Is Not Material and Is the Type That the Registrant Treats as Private or Confidential License Agreement Case Western Reserve University – Mosaic Immunoengineering, Inc
12/34/56
EX-10.1
from 8-K 3 pages Series a Preferred Stock Redemption Agreement
12/34/56
EX-10.1
from 8-K 22 pages Form of Convertible Note Purchase Agreement
12/34/56
EX-10.1
from 8-K 19 pages Form of Convertible Note Purchase Agreement
12/34/56
EX-10.1
from 10-Q 10 pages Mosaic ImmunoEngineering Inc. Consulting Agreement
12/34/56
EX-10.11
from 10-KT 12 pages Form of Indemnification Agreement
12/34/56
EX-10.10
from 10-KT 4 pages Mosaic ImmunoEngineering Inc. 2020 Omnibus Incentive Plan Notice of Stock Appreciation Rights
12/34/56
EX-10.9
from 10-KT 5 pages Mosaic ImmunoEngineering Inc. 2020 Omnibus Incentive Plan Notice of Restricted Stock Units
12/34/56
EX-10.8
from 10-KT 4 pages Mosaic ImmunoEngineering Inc. 2020 Omnibus Incentive Plan Notice of Restricted Stock
12/34/56
EX-10.7
from 10-KT 5 pages Mosaic ImmunoEngineering Inc. 2020 Omnibus Incentive Plan Notice of Non-Qualified Stock Option
12/34/56
EX-10.6
from 10-KT 5 pages Mosaic ImmunoEngineering Inc. 2020 Omnibus Incentive Plan Notice of Incentive Stock Option
12/34/56
EX-10.5
from 10-KT 16 pages Mosaic ImmunoEngineering Inc. Code of Business Conduct and Ethics Adopted November 3, 2020
12/34/56
EX-10.4
from 10-Q 2 pages Offer Letter - Paul Lytle
12/34/56
EX-10.3
from 10-Q 2 pages Offer Letter - Steven King
12/34/56
EX-10.1
from 8-K 2 pages Patriot Scientific Corporation Announces Name Change to “Mosaic Immunoengineering Inc.”, Stock Symbol Change and Reverse Stock Split
12/34/56
EX-10.14
from 10-Q 13 pages Materials Transfer, Evaluation and Exclusive Option Agreement
12/34/56
EX-10.13
from 8-K 109 pages Stock Purchase Agreement by and Among Patriot Scientific Corporation, as Parent PTSC Sub One, Inc., as Buyer Mosaic ImmunoEngineering Inc., as the Company the Stockholders of the Company Named Herein, as the Sellers and Steven King as the Sellers’ Representative Dated as of August 19, 2020
12/34/56
EX-10.1
from 8-K 8 pages Separation Agreement and General Release of All Claims
12/34/56
EX-10.1
from 8-K 10 pages Patriot Scientific Corporation, Inc. Consulting Agreement
12/34/56